Discovery & Development

Innovation that takes technology design to the physical limits

NIBRT Principle Investigator Jonathan Bones discusses the challenges involved in biotherapeutic protein characterization.

Great technology takes complex challenges and provides simple, robust solutions.

Drug discovery doesn’t always begin in the lab…

Researchers working to gain greater knowledge into crystallization believe that functionalized glass can trigger nucleation of specific crystals.

You have the perfect drug and the right packaging to protect it. All is well until the medication reaches the patient, who habitually pops the tablets into another container for easy storage or leaves them exposed to the atmosphere. Film coatings are more than just a pretty face.

The pressure for increased efficiency pervades the pharma industry, including the clinical trials sector, where traditional supply models can lead to overstocking, waste and higher costs. Is there a more effective supply strategy?

Will aerosol-based detectors ever meet all the needs of the pharmaceutical industry?

Could drug development be guided by a new algorithm that predicts the side effects of potential medicines?

Functionalized glass is shown to trigger nucleation of specific crystal forms